Non-Current Assets
PP&E (Net)
Revolution Medicines, Inc. PP&E (Net) decreased by 5.2% to $31.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.9%, from $27.15M to $31.48M. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 30.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
An increase indicates ongoing investment in physical capacity, whereas a decline may suggest aging assets or a strategy of asset-light operations.
Detailed definition
This metric represents the book value of tangible assets after subtracting accumulated depreciation from the total histo...
Peer comparison
Standard line item for all manufacturing and industrial companies; directly comparable across peers.
Metric ID:
property_plant_equipment_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.74M | $10.11M | $11.54M | $13.06M | $15.91M | $18.27M | $18.66M | $18.54M | $19.72M | $20.29M | $22.87M | $23.70M | $25.28M | $24.81M | $24.29M | $27.15M | $33.05M | $32.93M | $33.19M | $31.48M |
| QoQ Change | — | -5.9% | +14.2% | +13.1% | +21.9% | +14.8% | +2.1% | -0.7% | +6.4% | +2.9% | +12.7% | +3.6% | +6.7% | -1.9% | -2.1% | +11.8% | +21.7% | -0.4% | +0.8% | -5.2% |
| YoY Change | — | — | — | — | +48.1% | +80.7% | +61.6% | +42.0% | +23.9% | +11.1% | +22.5% | +27.8% | +28.2% | +22.3% | +6.2% | +14.6% | +30.7% | +32.7% | +36.7% | +15.9% |
Range$10.11M – $33.19M
CAGR+25.4%
Avg YoY Growth+31.6%
Median YoY Growth+28.0%
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s pp&e (net)?
- Revolution Medicines, Inc. (RVMD) reported pp&e (net) of $31.48M in Q1 2026.
- How has Revolution Medicines, Inc.'s pp&e (net) changed year-over-year?
- Revolution Medicines, Inc.'s pp&e (net) increased by 15.9% year-over-year, from $27.15M to $31.48M.
- What is the long-term trend for Revolution Medicines, Inc.'s pp&e (net)?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s pp&e (net) has grown at a 30.1% compound annual growth rate (CAGR), from $8.90M to $33.19M.
- What does pp&e (net) mean?
- The current book value of physical assets after accounting for wear and tear.